COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022

IMPORTANCE: Recent case reports document that some patients who were treated with Paxlovid experienced rebound COVID-19 infections and symptoms 2 to 8 days after completing a 5-day course of Paxlovid. The Centers for Disease Control and Prevention (CDC) has recently issued a Health Alert Network Hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lindsey, Berger, Nathan A., Davis, Pamela B., Kaelber, David C., Volkow, Nora D., Xu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258292/
https://www.ncbi.nlm.nih.gov/pubmed/35794889
http://dx.doi.org/10.1101/2022.06.21.22276724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258292/
https://www.ncbi.nlm.nih.gov/pubmed/35794889
http://dx.doi.org/10.1101/2022.06.21.22276724

Ejemplares similares